Detalles de la búsqueda
1.
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
Haematologica
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546691
2.
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.
Clin Immunol
; 251: 109637, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37150239
3.
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
Blood
; 130(16): 1819-1831, 2017 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28801451
4.
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas.
Haematologica
; 102(4): 755-764, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28104700
5.
A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphoma.
Br J Haematol
; 193(5): 1001-1004, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33942298
6.
The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
Br J Haematol
; 185(3): 616-620, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30198569
7.
Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.
Am J Pathol
; 181(1): 26-33, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22609116
8.
[Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases].
Zhonghua Bing Li Xue Za Zhi
; 42(9): 589-92, 2013 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-24314243
9.
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
J Hematol Oncol
; 16(1): 122, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104096
10.
[Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
Zhonghua Zhong Liu Za Zhi
; 34(2): 110-6, 2012 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-22780928
11.
[Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
Zhonghua Bing Li Xue Za Zhi
; 41(2): 91-6, 2012 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-22455884
12.
[Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Zhonghua Bing Li Xue Za Zhi
; 40(4): 220-6, 2011 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-21615994
13.
Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma.
J Cancer
; 12(20): 6126-6134, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34539885
14.
[Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
Zhonghua Bing Li Xue Za Zhi
; 39(5): 302-7, 2010 May.
Artículo
en Zh
| MEDLINE | ID: mdl-20654152
15.
[Solitary plasmacytoma of bone: a clinicopathologic, immunohistochemical and immunoglobulin gene rearrangement study].
Zhonghua Bing Li Xue Za Zhi
; 39(3): 177-82, 2010 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-20450765
16.
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.
Leukemia
; 34(1): 138-150, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171817
17.
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma.
Cancer Biol Med
; 16(3): 530-541, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31565482
18.
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
Cancer Cell
; 35(5): 752-766.e9, 2019 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085176
19.
MCL1 as a therapeutic vulnerability in Burkitt lymphoma.
Leukemia
; 37(4): 934-937, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36732564
20.
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.
J Clin Invest
; 128(12): 5517-5530, 2018 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260324